Akorn Announces Proposed Offering of $100 Million of Convertible Senior Notes Due 2016

jurisdiction in which such offer, solicitation, or sale would be unlawful. About Akorn, Inc. Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has...